Spectrum Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.02.19	Ausblick: Spectrum Pharmaceuticals gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
21.02.19	Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results Conference Call (Businesswire)
07.02.19	Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum on February 14 (Businesswire)
17.01.19	Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients (Businesswire)
02.01.19	Spectrum Pharmaceuticals Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations (Businesswire)
27.12.18	Spectrum Pharmaceuticals Announces Submission of Biologics License Application to the FDA for ROLONTIS® (eflapegrastim) as a Treatment for Chemotherapy-Induced Neutropenia (Businesswire)
20.12.18	Spectrum Pharmaceuticals Continues To Post Steep Loss (RTTNews)
20.12.18	7 Stocks That Made Big Moves After-hours (TLRY, SPPI, ADMA, DBVT...) (RTTNews)
19.12.18	Spectrum Pharmaceuticals Provides Poziotinib Update (Businesswire)
06.12.18	Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS® (eflapegrastim) at the 2018 SABCS Annual Meeting (Businesswire)
03.12.18	Spectrum Pharmaceuticals Announces Positive Results from Phase 2 Trial Evaluating Use of Oral Leucovorin to Potentially Mitigate Mucositis in Patients Treated with FOLOTYN® (pralatrexate) (Businesswire)
30.11.18	Spectrum Pharmaceuticals Highlights Three Posters at the 60th Annual Meeting of the American Society of Hematology (Businesswire)
13.11.18	Spectrum Pharmaceuticals Appoints Dr. Jeffrey Vacirca to its Board of Directors (Businesswire)
08.11.18	Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results (Businesswire)
07.11.18	Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 London Healthcare Conference on November 14 (Businesswire)
07.11.18	Ausblick: Spectrum Pharmaceuticals präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
01.11.18	Spectrum Pharmaceuticals Announces Third Quarter 2018 Financial Results Teleconference and Webcast (Businesswire)
23.10.18	Spectrum Pharmaceuticals Receives FDA Approval of KHAPZORY™ (levoleucovorin) for injection (Businesswire)
18.10.18	Spectrum Pharmaceuticals Announces Dr. Francois Lebel as Chief Medical Officer (Businesswire)
27.09.18	Spectrum Pharmaceuticals to Present Corporate Update at the 2018 Cantor Global Healthcare Conference on October 2 (Businesswire)
24.09.18	Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients (Businesswire)
22.09.18	Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) (RTTNews)
12.09.18	Spectrum Pharmaceuticals Expands Poziotinib Clinical Trial Into First-Line Therapy and Doses First Patient (Businesswire)
05.09.18	Spectrum Pharmaceuticals Announces Release of Poziotinib Abstract as Part of the IASLC 19th World Conference on Lung Cancer (Businesswire)
30.08.18	Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September (Businesswire)
09.08.18	Spectrum Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pipeline Update (Businesswire)
02.08.18	Spectrum Pharmaceuticals Announces Second Quarter 2018 Financial Results Teleconference and Webcast (Businesswire)
29.06.18	Spectrum Pharmaceuticals Presents ADVANCE Phase 3 ROLONTIS® (eflapegrastim) Data at MASCC 2018 and Announces the Phase 3 RECOVER Study Met the Primary Endpoint (Businesswire)
27.06.18	SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz (RTTNews)
25.06.18	Spectrum Pharmaceuticals to Host Conference Call Highlighting ROLONTIS® (eflapegrastim) Phase 3 ADVANCE Study Data Presented at Multinational Association of Supportive Care in Cancer (MASCC) (Businesswire)
30.05.18	Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2018 Global Healthcare Conference on June 6th (Businesswire)
16.05.18	Spectrum Pharmaceuticals Announces Detailed Results from Phase 3 Study of ROLONTIS® (eflapegrastim) Published in an ASCO Abstract (Businesswire)
09.05.18	Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2018 Health Care Conference on May 16th (Businesswire)
03.05.18	Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update (Businesswire)
03.05.18	Spectrum Pharmaceuticals Announces Exclusive Licensing Agreement on Certain Methods of Use of Poziotinib with The University of Texas MD Anderson Cancer Center (Businesswire)
01.05.18	Spectrum Pharmaceuticals Enters into a Next-Generation Sequencing Companion Diagnostic Partnership with Thermo Fisher Scientific (Businesswire)
30.04.18	Spectrum Pharmaceuticals Announces Corporate Governance Enhancements and Board Changes (Businesswire)
26.04.18	Spectrum Pharmaceuticals Announces First Quarter 2018 Financial Results Teleconference and Webcast (Businesswire)
23.04.18	Spectrum Pharmaceuticals Announces Publication of Poziotinib Data in Nature Medicine (Businesswire)
11.04.18	SPPI Shines On NSCLC Data, TNDM Sales Up 42%, TORC Breathes Easy, VRAY Abuzz (RTTNews)
10.04.18	Spectrum Pharmaceuticals Announces Update of MD Anderson’s Phase 2 Data Studying Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer Patients (Businesswire)
03.04.18	Spectrum Pharmaceuticals to Present Corporate Update at the H.C. Wainwright Global Life Sciences Conference on April 10th (Businesswire)
07.03.18	Spectrum Pharmaceuticals to Present Corporate Update at the Cowen and Company 38th Annual Health Care Conference on March 13th (Businesswire)
06.03.18	Spectrum Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results and Pipeline Update (Businesswire)
27.02.18	Spectrum Pharmaceuticals Announces Appointment of William L. Ashton to its Board of Directors (Businesswire)
26.02.18	Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results Teleconference and Webcast (Businesswire)
15.02.18	Spectrum Pharmaceuticals to Present Corporate Update at the 2018 RBC Capital Markets Global Healthcare Conference on February 22nd (Businesswire)
06.02.18	Xtandi Prospers, One Down, One To Go For AMAG, There's Reason For CORT's Fall (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Spectrum Pharmaceuticals IncShs

Aktien Top/Flop

Meistgelesene Nachrichten